Code 0174A is effective now for patients ages 6 months to 4 years. On March 14, 2023, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the bivalent Pfizer-BioNTech COVID-19 vaccine to allow providers to administer a booster to certain young patients. As a result, on March 17, the American Medical […]
The post New COVID-19 Code for Bivalent Booster appeared first on AAPC Knowledge Center.